Discussion questions about the therapy of nonchemical addictions

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Today there are no international standards for the treatment of non-chemical (behavioral) addiction (NA). This is largely due to the vagueness of their existence as nosological units and, as a consequence, their place in international classifications. This article discusses the forms of NA that are or will be included in DSM-V and ICD-11. It has been shown that NA research has sparked discussions about the spectrum of addictive disorders, expands the multidisciplinary understanding of the etiology and pathogenesis of addictive disorders, and promotes the study of new forms and expansion of therapeutic approaches. The criticism of the addictive spectrum concept is analyzed. The modern approaches of non-drug and pharmacological therapy of different forms of NA are presented.

The following conclusions are drawn.

  1. The existence of NA is confirmed by the inclusion of a part of them in the International Classifications of Diseases.
  2. NA have high comorbidity with other mental disorders, in respect of which pharmacotherapy and psychotherapy are not in doubt.
  3. Taking into account the general neurobiological mechanisms of the formation of addictive disorders, the possible pharmacotherapy of non-chemical addictions, officially recognized in the ICD and DSM, should proceed from the currently available approaches to the therapy of substance use disorders.
  4. Treatment of non-chemical addictions that are not included in the International Classifications can only be carried out within the framework of therapy for confirmed comorbid mental disorders. In its absence, psychological correction seems to be possible.
  5. There is an obvious need to continue researching the problem of non-chemical addictions to expand new approaches to their therapy and psychological correction.

About the authors

Alexey Y. Egorov

I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry of Russian Academy of Sciences; I.I. Mechnikov Northwestern State Medical University; St. Petersburg State University

Author for correspondence.
Email: draegorov@mail.ru
ORCID iD: 0000-0002-5737-8560

доктор медицинских наук, профессор, заведующий лабораторией нейрофизиологии и патологии поведения

Russian Federation, 194223, St. Petersburg, pr. Toreza, 44; 191015, St. Petersburg, Kirochnaya str., 41; 199034, St. Petersburg, Universitetskaya Embankment, 7–9

References

  1. Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association. Washington, DC, London, England: American Psychiatric Publishing. 2013; 970 p.
  2. World Health Organization. ICD-11 beta draft — Mortality and morbidity statistics. Mental, behavioural or neurodevelopmental disorders. 2018. https://icd.who.int/dev11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f334423054 (access date: 02.02.2021).
  3. Международная классификация болезней (10-й пересмотр). Классификация психических и поведенческих расстройств. Клинические описания и указания по диагностике. Пер. на рус. яз. Под ред. Ю.Л. Нуллера, С.Ю. Циркина. СПб.: Адис. 1994; 302 с. [Mezhdunarodnaja klassifikacija boleznej (10-j peresmotr). Klassifikacija psihicheskih i povedencheskih rasstrojstv. Klinicheskie opisanija i ukazanija po diagnostike. Per. na rus. jaz. Pod red. Ju.L. Nullera, S.Ju. Cirkina. SPb.: Adis. 1994; 302 р. (In Russ.)]
  4. Demetrovics Z., Griffiths M. Behavioral addictions: Past, present and future. J. Behav. Addict. 2012; 1 (1): 1–2. doi: 10.1556/JBA.1.2012.1.0.
  5. Егоров А.Ю. Аддиктивный спектр: pro et contra. Неврологич. вестн. 2020; 52 (4): 60–68. [Egorov A.Yu. Addiktivnyj spektr: pro et contra. Nevrologicheskij vestnik. 2020; 52 (4): 60–68. (In Russ.)] doi: 10.17816/nb49780.
  6. Короленко Ц.П., Шпикс Т.А. Постпсихиатрия: спектры психологических и психических нарушений. Новосибирск: Изд.-полиграф. центр НГМУ. 2018; 154 с. [Korolenko C.P., Shpiks T.A. Postpsihiatrija: spektry psihologicheskih i psihicheskih narushenij. Novosibirsk: Izd.-poligraf. centr NGMU. 2018; 154 р. (In Russ.)]
  7. Grant J.E., Potenza M., Weinstein A., Gorelick D.A. Introduction to behavioral addictions. Am. J. Drug Alcohol Abuse. 2010; 36 (5): 233–241. doi: 10.3109/00952990.2010.491884.
  8. Менделевич В.Д. Фейк-диагнозы в психиатрических классификациях. Неврологич. вестн. 2018; 50 (4): 15–18. [Mendelevich V.D. Fejk-diagnozy v psihiatricheskih klassifikacijah. Nevrologicheskij vestnik. 2018; 50 (4): 15–18. (In Russ.)]
  9. Снедков Е.В. Поведенческие эпифеномены в международной классификации болезней. Неврологич. вестн. 2019; 51 (3): 5–19. [Snedkov E.V. Povedencheskie jepifenomeny v mezhdunarodnoj klassifikacii boleznej. Nevrologicheskij vestnik. 2019; 51 (3): 5–19. (In Russ.)]
  10. Снедков Е.В. Повышает ли психометрия качество психиатрической диагностики? Неврологич. вестн. 2020; 52 (3): 15–20. [Snedkov E.V. Povyshaet li psihometrija kachestvo psihiatricheskoj diagnostiki? Nevrologicheskij vestnik. 2020; 52 (3): 15–20. (In Russ.)]
  11. Mendelevich V.D. Toward diagnostic and therapeutic relativism in psychiatry and addiction medicine. Heroin Addict. Relat. Clin. Probl. 2019; 21 (5): 9–14.
  12. Менделевич В.Д. Нейромания и нейрофобия: как в психиатрии «физики» побеждают «лириков». Неврологич. вестн. 2020; 52 (4): 8–11. [Mendelevich V.D. Nejromaniya i nejrofobiya: kak v psihiatrii “fiziki” pobezhdayut “lirikov”. Nevrologicheskij vestnik. 2020; 52 (4): 8–11. (In Russ.)] doi: 10.17816/nb49814.
  13. Хмарук И.Н., Степанова Ю.С. Социально-психологическая предиспозиция формирования эротических аддикций. В сб.: Бехтерев В.М. и современная психология. Материалы докладов на российской научно-практической конференции. Казань, КГУ, 29–30 сентября 2005 г. Вып. 3. Т. 2. Казань: Центр инновационных технологий. 2005; 332–338. [Hmaruk I.N., Stepanova Yu.S. Social’no-psihologicheskaya predispoziciya formirovaniya eroticheskih addikcij. In: Bekhterev V.M. i sovremennaya psihologiya. Materialy dokladov na rossijskoj nauchno-prakticheskoj konferencii. Kazan’, KGU, 29–30 sentyabrya 2005 g. Vyp. 3. T. 2. Kazan’: Centr innovacionnyh tekhnologij. 2005; 332–338. (In Russ.)]
  14. Егоров А.Ю. Любовные аддикции. Вестн. психиатрии и психол. Чувашии. 2015; 11 (2): 64–81. [Egorov A.Yu. Lyubovnye addikcii. Vestnik psihiatrii i psihologii Chuvashii. 2015; 11 (2): 64–81. (In Russ.)]
  15. Егоров А.Ю. Социально-приемлемые поведенческие зависимости. Saarbrüken: Lambert. 2016; 113 c. [Egorov A.Yu. Social’no-priemlemye povedencheskie zavisimosti. Saarbrüken: Lambert. 2016; 113 р. (In Russ.)]
  16. Zeki S. The neurobiology of love. FEBS Lett. 2007; 581 (14): 2575–2579. doi: 10.1016/j.febslet.2007.03.094.
  17. Егоров А.Ю. Терапия нехимической зависимости. Ж. неврол. и психиатрии им. С.С. Корсакова. 2018; 118 (6): 115–123. [Egorov A.Yu. Terapiya nekhimicheskoj zavisimosti. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2018; 118 (6): 115–123. (In Russ.)] doi: 10.17116/jnevro201811861115.
  18. Егоров А.Ю., Гречаный С.В. Современные подходы к терапии и коррекции Интернет-аддикции. Ж. неврол. и психиатрии им. С.С. Корсакова. 2019; 119 (6): 101–108. [Egorov A.Yu., Grechanyj S.V. Sovremennye podhody k terapii i korrekcii Internet-addikcii. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2019; 119 (6): 101–108. (In Russ.)] doi: 10.17116/jnevro2019119061152.
  19. Aboujaoude E., Salame W.O. Naltrexone: A pan-addiction treatment? CNS Drugs. 2016; 30 (8): 719–733. doi: 10.1007/s40263-016-0373-0.
  20. Mouaffak F., Leite C., Hamzaoui S. et al. Naltrexone in the treatment of broadly defined behavioral addictions: A review and meta-analysis of randomized controlled trials. Eur. Addict Res. 2017; 23 (4): 204–210. doi: 10.1159/000480539.
  21. Piquet-Pessôa M., Fontenelle L.F. Opioid antagonists in broadly defined behavioral addictions: a narrative review. Expert Opin. Pharmacother. 2016; 17 (6): 835–844. doi: 10.1517/14656566.2016.1145660.

Copyright (c) 2021 Egorov A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies